Although general unknown screening (GUS) is often used to detect and identify exogenous compounds in biological matrices, some compounds are not detected for two main reasons: first the method carried out for the extraction, secondly, the lack of sensitivity in the detection of the unknown molecules. The aim of this study was to improve the detection, using an acidic extraction procedure and a MRM mode (ES + or ES − ). Methods: Blank sera were spiked with 42 substances, not detected in GUS. 1 mL was extracted after addition of internal standards and 500 μL of acetate buffer by 3 mL of organic extraction solution (dichloromethane: ether: hexane: isoamyl alcohol; 30:50:20:0.5, v/v). Basic extraction was also carried out by substituting the sodium acetate buffer with saturated borate buffer. The extracts were analysed by UPLC-MS-MS, using MRM mode (ES + or ES − ). Results: All the non detected substances by the GUS method were indentified in this study, 25 in ES + mode and 17 in ES − mode. Extraction yield was between 9 and 104%, and upper, compared to that after basic extraction. Conclusion: A rapid, sensitive and selective method using positive or negative MRM mode, with a triple quadrupole mass spectrometer and a simple acidic liquidliquid extraction allows to identify, confirm and quantify 42 substances (drugs and pesticides) not detected by a routine GUS method. Mots clés : Screening large de recherche des xénobiotiques, extraction acide, détection en mode MRM
Introduction
General unknown screening (GUS) is often used to detect and identify exogenous compounds in various biological maCorrespondence: C. Richeval, camille.richeval@chru-lille.fr trices (blood, urine or hair) in clinical and forensic toxicology, but with very different concentrations depending on the circumstances of poisoning (acute poisoning or chemical submission). The screening of xenobiotics can be carried out using untargeted separative methods and identification by GC-MS Article published by EDP Sciences [1] [2] [3] , GC-MS/MS [4] [5] [6] , HPLC-DAD [7] , HPLC/MS [8, 9] , HPCL-MS/MS [10, 11] , UPLC-MS [12] , or UPLC-MS/MS [13] . In these screenings, the identity of the compounds is established by comparison of the obtained spectra (UV or mass/z) with reference spectra from commercial or in-house made libraries.
Nowadays, LC-MS (-MS) or UPLC-MS (-MS) is used routinely in the framework of analysis prescribed in clinical or forensic toxicology, because this technology allows the detection of the largest number of compounds. However, some compounds are not detected in GUS, for two main reasons. The first is the method carried out for the extraction of the unknown molecules contained in the biological matrix; the second reason is the lack of sensitivity in the detection for these molecules. For this last point, Multi Reaction Monitoring (MRM) mode in mass spectrometry improves the detection limit of these compounds, but this acquisition only allows targeted research due to a setting of many specific MRM transitions.
Another point, the sample preparation (extraction from a biological matrix) is a step that must be evaluated and controlled, for obtaining the best limit of detection. A lot of molecules have been detected, because the authors focused on one substance [14] , or on a given therapeutic class, such as benzodiazepines [15] . It is clear that a sample preparation method which is specifically directed toward a molecule or a group of similar molecules will be the most efficient and probably more sensitive, but will require other extractions to detect other molecules, potentially present. The repetition of extractions is laborious and requires larger sample.
A screening of xenobiotics by UPLC-MS using in-source fragmentation at increasing cone voltages has been described [13] . The xenobiotics were detected after mixture of two extractions one under acidic conditions, the other under basic conditions, by ionization in both ES + and ES − . In this work, some xenobiotics (drugs or pesticides) were not detectable probably due to the sample preparation or a lack of sensitivity of the mass spectrometer. The aim of the study was to improve the detection of these compounds; an acidic extraction protocol was here investigated for the detection of these molecules in blood and compared to a basic extraction. MRM mode using ES + or ES − was applied in order to improve detection of the different compounds.
Materials and methods

Standards and reagents
HPLC-grade methanol and acetonitrile were from Carlo Erba (Val de Reuil, France) and from JT Baker (France), respectively. Ammonium formate and formic acid were obtained from Sigma-Aldrich (Saint Quentin Fallavier, France). Deionized water (Versol was obtained from Aguettant, (France). All remaining organic solvents and reagents were of analytical grade and obtained from the suppliers indicated: dichloromethane (Carlo Erba, France); diethylether (Panreac, France); hexane (Sharlau, France) and isoamyl alcohol (Merck, France).
Drug substances were supplied by various pharmaceutical companies. Individual stock solutions of the standard compounds were prepared in methanol at 1 g/L; these were kept at -20
• C until use. Methylclonazepam and β-hydroxy ethyl theophylline were used as internal standards and were obtained from Roche (France) and Sigma-Aldrich, respectively. A mixed stock solution (IS mix) was prepared in methanol at 1.25 and 16 mg/L, respectively, and stored at -20
• C until analysis.
Biological specimens
Blank human serum was obtained from EFS (Etablissement Français du Sang Lille, France).
Liquid chromatography conditions
The chromatographic system comprised an Acquity UPLC (Waters Corporation, MA, USA). Analytes were separated using an Acquity UPLC HSS C 18 , 2.1 × 150 mm, 1.8 μm column (Waters Corporation, MA, USA) maintained at 50
• C. The mobile phase was a binary mixture of formate buffer 5 mM pH 3.0, adjusted with formic acid (A) and acetonitrile containing 0.1% formic acid (B) at a flow rate of 400 μL/min (generating a typical back-pressure of ∼9000 psi) (0 min. = 87% A; 6-7 min = 5% A; 7.25-10 min = 87% A). An injection volume of 15 μL was used throughout.
Mass spectrometry conditions
Detection was performed using a Waters TQ Detector, tandem quadrupole mass spectrometer (Waters Corporation, MA, USA) equipped with a Z-Spray TM source and ES probe. The instrument was controlled using Waters MassLynx TM v4.1.
Ionization was performed in ES
+ and in ES − . Source conditions were as follows: source temperature was maintained at 150
• C; capillary voltage: 1000 V; extractor cone: 3V; cone gas flow rate: 50 L/h; desolvation gas flow rate and temperature: 650 L/h and 350
• C, respectively. Infusions were performed at 10 μL/min with variations of the cone voltage, energies of accelerations for optimisation.
For each compound, the MRM transitions, cone voltage and collision energy are indicated in Table I .
Preparation of the solutions
Working solutions of the drugs or pesticides of interest were prepared by dilution of the stock solution with the mobile phase to obtain a concentration of 1 000 ng/mL. Small volumes were analysed in two separate infusion analyses; one in ES + and one in ES − to optimize and obtain two transitions MRM (Table I ).
Data processing
All data were processed using the QuanLynx application manager (Waters Corporation, MA, USA). This software permits the integration of MRM peaks at specific retention times and the calculation of their areas. 
Biological sample preparation
Blank sera were spiked with the substances approximately at high therapeutic concentrations, when these concentrations were known. When the therapeutic concentrations of the drug were unknown, or when the compound was a pesticide, concentration less than 5000 ng/mL was tested. Blank serum and spiked serum were prepared by a liquid-liquid extraction (LLE) by acidic extraction. One milliliter of biological sample, 100 μL of the IS mix and 500 μL sodium acetate buffer (1 M, pH 3.5) were added to a 10 mL Kimble tube and mixed. Samples were extracted by the addition of 3 mL organic extraction solution (dichloromethane: ether: hexane: isoamyl alcohol; 30:50:20:0.5, v/v). Samples were vortex-mixed for 2 min before centrifugation at 3000× g for 5 min. The upper, organic layer was transferred to a clean vial.
A basic extraction was also carried out using the same procedure, by substituting the sodium acetate buffer with a saturated borate buffer (pH 9.0)
The supernatant was evaporated under nitrogen at 60
• C. Dried extracts were reconstituted in 100 μL of mobile phase and vortex-mixed for 2 min before analysis.
A limit of detection has been estimated, using the highest therapeutic concentration or this last concentration by dilution 1:10 or 1:100. For substances for which the therapeutic concentrations were unknown and for the pesticides, an arbitrary concentration was first tested, and then diluted 1:10 and 1:100.
Table II indicates the 42 tested xenobiotics. For each compound, the therapeutic, toxic and lethal concentrations (when known), the mode of ionization and the chosen transitions for the identification of drugs are described. Twenty five substances were detected in ES + mode and 17 in ES − mode. The yield of extraction was estimated after extraction in acidic (acetate buffer) or basic (borate buffer) condition. The results show clearly a better extraction using acetate buffer (Table II).
A limit of detection has been estimated, permitting the detection of all the studied compounds and the measurement of low, detectable concentrations for some compounds (Table II) .
Discussion
Several general unknown screenings have been described for the detections of xenobiotics, but often the analytical protocol targeted a specific pharmacological class of drugs [16] [17] [18] or pesticides [6, 8] .
In our original, systematic GUS procedure using a double extraction (basic and acidic), some substances were not detected [13] . Extraction of the substances was then carried out in acid and basic condition. The sensitivity of the detection has been increased by using MRM mode of detection, either in positive or negative mode. In this way, all the molecules could be detected, using only the acidic, at least at therapeutic concentrations (or less) for the drugs. Therefore, the screening described by Humbert et al. [13] is used for the GUS, and an acidic extraction is also carried out for those undetectable molecules, with detection by MRM mode. The two protocols are rapid and with the use of UPLC-MS-MS, the results are obtained in about 15 min for the routine procedure and 10 min in MRM mode for the acidic procedure.
Conclusion
We have developed a rapid, sensitive and selective UPLC-MS/MS method using a positive or negative MRM mode, with a triple quadruple mass spectrometer and a simple acidic liquid-liquid extraction with small sample size to identify, confirm and quantify 42 substances (drugs and pesticides) that were not detected by the routine GUS method used in our laboratory.
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